Immunization with antigen-pulsed mature DCs, which aims to elicit antitumor T cell responses, may in fact also lead to significant antitumor immunity in an NK cell-dependent manner, reflecting interplay between DC, NK and CD4+ and/or CD8+ T-cells as reported in melanoma and other tumor models [35, 36]. The gene discussed is CD8A; the disease is neoplasm.